Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_assertion type Assertion NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_head.
- NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_assertion description "[In conclusion, MDM2 and CDK4 immunostainings, which correlate with gene amplification, are helpful adjuncts to differentiate ALT-WDLPS from benign adipose tumors and to separate DDLPS from poorly differentiated sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_provenance.
- NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_assertion evidence source_evidence_literature NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_provenance.
- NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_assertion SIO_000772 16160477 NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_provenance.
- NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_assertion wasDerivedFrom befree-20150227 NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_provenance.
- NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_assertion wasGeneratedBy ECO_0000203 NP301614.RATbnHgzSBO9f5uf4ZqDCB9RPlFfM8lb5Yttd5Yjv-FGY130_provenance.